Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    royal marsden AND colorectal cancer AND methotrexate
Previous Study | Return to List | Next Study

Methotrexate in Metastatic Colorectal Cancer With MSH2 Deficiency (MESH)

This study has been terminated.
(Lack of recruitment - only 2 patients recruited.)
Sponsor:
Information provided by (Responsible Party):
Royal Marsden NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT00952016
First received: July 31, 2009
Last updated: October 13, 2016
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)